CureMetrix

CureMetrix is a medical imaging company founded in 2014 on the belief that AI can close the gap between what medicine is capable of and what patients actually receive. It builds imaging tools for radiologists — precision AI that integrates into existing workflows and helps clinicians detect what matters sooner, with a focus on women's health from breast cancer to heart disease. Its FDA-cleared cmAngio detects, quantifies, and contextualizes Breast Arterial Calcifications (BAC) from routine mammograms, and its cmTriage is described as the first FDA-cleared AI tool for mammography workflow optimization. The company states its technology is live in over 400 sites across the US.

CureMetrix was founded in 2014 on the belief that AI can close the gap between what medicine is capable of and what patients actually receive. The company builds imaging tools for radiologists — precision AI that integrates into existing workflows and helps clinicians detect what matters sooner. It frames its mission around women's health, stating that from breast cancer to heart disease, the consequences of a late diagnosis fall hardest on women. Its FDA-cleared cmAngio detects, quantifies, and contextualizes Breast Arterial Calcifications (BAC) from routine mammograms, and the company states its technology is live in over 400 sites across the US. CureMetrix also offers cmTriage, described as the first FDA-cleared AI tool for mammography workflow optimization, and lists cmAssist as in development for cancer detection scoring.

Precision AI imaging tools for radiologists that integrate into existing workflows, focused on improving healthcare for women globally.

• cmAngio 2.0

  FDA-cleared AI that detects, quantifies, and contextualizes Breast Arterial Calcifications (BAC) from routine screening mammograms, providing objective BAC extent measurements, age-based contextualization through the CureMetrix Reference Library, enhanced scorecards, and FHIR-enabled interoperability.

• cmTriage

  The first FDA-cleared AI tool for mammography workflow optimization; it prioritizes mammography cases, flags suspicious findings for immediate radiologist review, and reduces turnaround time for critical cases.

• cmAssist

  Listed as in development for cancer detection scoring.

1. 1CureMetrix cmAngio FDA Cleared AI for Mammographycuremetrix.com
2. 2About CureMetrix — Mission, Team & Locationscuremetrix.com
3. 3CureMetrix Products — AI-Powered Mammography Solutionscuremetrix.com